Search   Advanced Search Help | Site Index | Contact Us All |  A |  B |  C |  D |  E |  F |  G |  H |  I |  J |  K |  L |  M |  N |  O |  P |  Q |  R |  S |  T |  U |  V |  W |  X |  Y |  Z Title Last Updated A "State-of-the-Art" Conference on Hepatitis C May 6, 2008 A Case Study Approach to the Clinician's Challenge in Preserving Long-term Renal Function, Implication of Preserving Long-term Renal Function After Renal Transplantation, NIAID, NIH, DHHS Oct. 25, 2007 A Deadly Synergy, Tuberculosis (TB), NIAID, NIH April 1, 2005 A Delicate Balance: Levels of HIV Replication are Strongly Influenced by Interaction of Positive and Negative Host Factors July 9, 1996 A Framework for Progress on Hepatitis C May 6, 2008 A Global Threat, Leishmaniasis, NIAID, NIH Aug. 11, 2008 A Killer Returns: The Face of the Epidemic, Tuberculosis, NIAID, NIH April 1, 2005 A Leading Cause of Blindness May Be Controlled by Simple Course of Oral Antibiotic Aug. 19, 1999 A Microbe Hunter On Call to the World, Discovery News, NIAID, NIH May 9, 2008 A Multiple-reach Model Describing the Migratory Behavior of Snake River Yearling Chinook Salmon (Oncorhynchus tshawytscha), Can. J. Fish. Aquat. Sci. 55, 1998 Aug. 6, 2007 A New Registry for Primary Immune Deficiency Diseases Oct. 30, 1997 A Parasite, a Virus, and a Bacterium: NIAID's Plan to Tackle the World's Leading Killers, NIAID May 7, 2001 A Phase IIB randomized, controlled trial to evaluate the safety, tolerance, and HIV vertical transmission rates associated with short course nevirapine (NVP) vs. short course zidovudine (ZDV) in HIV infected pregnant women and their infants in Uganda July 15, 1999 A Potential New Target for Treating Asthma, NIAID, NIH Dec. 1, 2006 A Risky Business, Anthony S. Fauci, Washington Times, November 30, 2004 Aug. 6, 2007 A Safety Evaluation of MDCK for Influenza Vaccine Production, Vaccine Cell Substrate 2004, Practical Experience April 11, 2008 A Small Genetic Change Makes Flu Virus Deadly Sept. 6, 2001 A Timely Test: Real Time PCR, Tuberculosis (TB), NIAID, NIH April 1, 2005 A view from Washington through the eyes of an AAP physician-scientist, Anthony Fauci, Journal of Clinical Investigation, October 2007 Dec. 26, 2007 Abnormal Immune Cells May Cause Unprovoked Anaphylaxis Nov. 13, 2007 About CMB, Comparative Medicine Branch July 6, 2006 About NIAID June 14, 2005 About NIAID Labs March 13, 2007 About the DAIDS Clinical Research Policies and Standard Procedures Documents, NIAID, NIH Nov. 28, 2007 About the DMID Office of Clinical Research Affairs (OCRA), NIAID, NIH April 19, 2007 About the Research Technologies Branch, NIAID, NIH Sept. 5, 2006 About the TB Bug, Tuberculosis, NIAID, NIH April 1, 2005 About, NIAID HIV and Emerging Infectious Diseases Program, NIAID, NIH Oct. 17, 2006 Abstract: “Enteric Vaccines for Pediatric Use” Workshop Report, April 24-26, 2004, NIAID, NIH Aug. 6, 2007 Abstract: “Hit” to Clinical Candidate: Discovery and Characterization of the Aminomethylcyclines Sept. 7, 2007 Abstract: Antiviral Drug Development for Biothreat Agents, Tove C. Bolken, Head of Research Operations, SIGA Technologies, Inc. Sept. 7, 2007 Abstract: Bacillus anthracis Antimicrobials Derived from Inhibitors of Mammalian Serine-Threonine Kinases, Jimmy D. Ballard, Ph.D. Sept. 7, 2007 Abstract: Challenges of Antibiotic Drug Development in the 21st Century, Karen Bush, Ph. D., Sept. 7, 2007 Abstract: Chop-lump Tests for Vaccine Trials, September 4, 2007 Sept. 20, 2007 Abstract: Combining Focused Antisense Screening Technology (FAST) and Structure-based Drug Design (SBDD) for Antibacterial Discovery Sept. 7, 2007 Abstract: Development of Antiviral RNA Interference Therapeutics, Antonin de Fougerolles Sept. 7, 2007 Abstract: Development of Cysteine Cathepsin Inhibitors as Anti-Ebola Virus Agents - James M. Cunningham Sept. 7, 2007 Abstract: Discovery of Smallpox Inhibitors that Block Processive DNA Synthesis Sept. 7, 2007 Abstract: Dose and Schedule Choices to Suppress Emergence of Resistance G.L. Drusano, M.D., Ordway Research Institute Sept. 7, 2007 Abstract: Efflux Pump Inhibitors: from Tools to Drugs Sept. 7, 2007 Abstract: Identification of Inhibitors of Ebola Virus Using a Subgenomic Replication System Sept. 7, 2007 Abstract: Identification of Small Molecule Inhibitors of Anthrax Lethal Factor Sept. 7, 2007 Abstract: Impact of Drug-Like Properties on Hit Selection and Optimization for Quality Clinical Candidates Sept. 7, 2007 Abstract: Leveraging Structure-Based Drug Design Technologies to Accelerate Drug Candidate Generation Sept. 7, 2007 Abstract: Multi-target Anthrax Antitoxin Therapies, February 7, 2007 Sept. 7, 2007 Abstract: Nucleotides as Anti-HBV Agents, R. P. Iyer, Ph.D. Sept. 7, 2007 Abstract: Old Target, New Approach: Developing Pterin-like Small Molecules as Inhibitors of the Bacterial Folate Pathway Sept. 7, 2007 Abstract: Optimizing the Oral Bioavailability and Activity of Antiviral Drugs, Karl Y. Hostetler Sept. 7, 2007 Abstract: Pitfalls of Target Validation for Novel Antibacterial Strategies, David J. Payne Sept. 7, 2007 Abstract: The Discovery of Orally Active Inhibitors of Respiratory Syncytial Virus, Nicholas A. Meanwell Sept. 7, 2007 Abstract: Use of a Cocktail to Reduce the Need for Drug Interaction Studies During Drug Development - Joseph S. Bertino Jr., Pharm.D., FCP Sept. 7, 2007 Acellular Pertussis Vaccine Proves Effective in Adults, Adolescents Oct. 12, 2005 Achievements and Goals, Chemical Countermeasures, NIAID, NIH March 3, 2008 Achieving and Maintaining Polio Eradication, Polio Immunization: Moving Forward, September 19-20, 2007 Dec. 26, 2007 Acquired Immunodeficiency Review Committee, About NIAID, NIAID, NIH July 22, 2004 Acquired Immunodeficiency Syndrome (AIDS) Panel, US-Japan Cooperative Medical Science Program, NIAID, NIH Nov. 16, 2007 Acquired Immunodeficiency Syndrome (AIDS), Selected Scientific Areas of Research Dec. 23, 2004 Acronyms, Comparative Medicine Branch July 2, 2006 ACTG 175, CPCRA 007 Trial Results Published Oct. 9, 1996 ACTG 175: Anti-HIV Therapy Lowers Risk of AIDS Sept. 14, 1995 ACTG 315 Preliminary Results: Drug Cocktail Restores Partial Immune Function Jan. 26, 1997 Actividades del Día de Concientización Sobre la Vacuna Contra el VIH/SIDA, 18 de mayo del 2005 July 30, 2007 Actividades del Día de Concientización Sobre las Vacunas Contra el VIH 18 de Mayo del 2006 July 30, 2007 Acute Respiratory Infections Panel, US-Japan Cooperative Medical Science Program, NIAID, NIH March 10, 2005 Adaptively Changing Subgroup Proportions in Clinical Trials, Dean Follman, Statistica Sinica 1997 July 25, 2007 Add Your Voice, Division of AIDS (DAIDS), NIAID, NIH Sept. 11, 2008 Add Your Voice: Opportunties for Community Participation in HIV/AIDS Research, DAIDS, NIAID, NIH July 30, 2007 Adding IL-2 to Potent Anti-HIV Drugs Increases CD4+ T-Cell Counts Without Raising HIV Levels July 8, 2000 Additional Questions and Answers to RFP NIH-NIAID-DMID-PR2004-01 ‘Neutralizing Monoclonal Antibodies Type A for Botulinum Neurotoxins’ Sept. 12, 2007 Additional Questions and Answers to the RFP No. NIH-NIAID-DMID-PR2004-02, ‘Recombinant Type E Botulinum Neurotoxin Vaccine’ Sept. 12, 2007 Additional Resources, HIV/AIDS Specimen Repository May 15, 2008 Additional Resources, New Investigator Workshot, DAIT, NIAID, NIH Nov. 7, 2007 Addressing Antimicrobial Resistance, Slide 7, Testimony of Dr. Fauci, February 25, 1999 Feb. 24, 1999 Addressing Health Disparities: NIAID Agenda, Slide 9, Dr. Anthony S. Fauci, March 1, 2000 March 1, 2000 Adenovirus Potency Assays: Novel Approaches to Current Challenges April 11, 2008 Adjournment, National Advisory Allergy and Infectious Diseases Council January 2005 Minutes March 15, 2005 Adjournment, National Advisory Allergy and Infectious Diseases Council September 1997 Minutes March 13, 2001 Adjournment, National Advisory Allergy and Infectious Diseases Council: February 2000 Minutes March 2, 2001 Adjournment, National Advisory Allergy and Infectious Diseases Council: September 1998 Minutes March 12, 2001 Adjuvants and Other Vaccine Ingredients, Vaccines, NIAID, NIH Sept. 4, 2008 Adriana Marques, M.D., Clinical Studies Unit, Laboratory of Clinical Infectious Diseases, NIAID, NIH June 13, 2008 Adult Male Circumcision Reduces Risk of HIV Acquisition for at Least 3.5 Years Aug. 11, 2008 Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV: Trials in Kenya and Uganda Stopped Early Dec. 13, 2006 Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV: Trials in Kenya and Uganda Stopped Early Dec. 13, 2006 Advanced Product Development for Multiplex Infectious Disease Diagnostics: Summary of a NIAID Workshop Aug. 6, 2007 Advances in AIDS Pathogenesis and Preclinical Vaccine Development April 29, 1997 Advances in Treatment, Flu (Influenza), NIAID, NIH Nov. 28, 2006 Advances in Treatment, Tuberculosis (TB), NIAID, NIH July 17, 2008 Adventitious Virus Tests, Vaccine Cell Substrates 2004, June 30, 2004 April 11, 2008 Advisory and Working Groups, HIV/AIDS Vaccines, NIAID, NIH Sept. 12, 2007 Aedes Aegypti Announcement, October 2005, Pathogen Genomics, Research, NIAID, NIH Jan. 5, 2006 Aedes Announcement, June, Pathogen Genomics, Research, NIAID, NIH July 26, 2006 Aerosol Challenge Technology and Applications in Biodefense “Biological Safety” Sept. 12, 2007 Aerosol Challenge Technology and Applications in Biodefense, Biodefense, NIAID, NIH Feb. 7, 2007 Aerosol delivery of MTB and Chemotherapeutics: Pitfalls and Plans, Laura E. Via, Ph.D. Sept. 12, 2007 Aerosol Generation Sept. 12, 2007 Aerosol Parameters (Historical) Sept. 12, 2007 Aerosolized filoviruses in three species of nonhuman primates: Differences in disease course and pathology Dec. 26, 2007 Africa Malaria Day and Malaria Awareness Day, April 25, 2007, NIAID, NIH April 25, 2007 Africa, Global Research, NIAID, NIH Sept. 15, 2008 African Americans Inspiring Hope May 17, 2005 African Americans: Answers about HIV Vaccine Research, NIAID, NIH Sept. 11, 2008 Age of Optimism, Tuberculosis (TB), NIAID, NIH Feb. 28, 2006 Age-Based Screening is Cost-Effective Method to Control Chlamydial Infection Feb. 17, 1998 Agenda - OPV Dec. 26, 2007 Agenda, 40th Tuberculosis and Leprosy Research Conference, US-Japan Cooperative Medical Science Program, NIAID, NIH July 25, 2007 Agenda, Mycobacteria Symposium, NIAID, NIH Sept. 3, 2008 Agenda, Pediatric Tuberculosis Meeting, NIAID, NIH June 3, 2008 Agenda, Polio Immunization: Moving Forward, September 19-20, 2007, NIH Aug. 1, 2007 Agenda, Vaccines for Viral Infections in Developing Countries Aug. 2, 2006 Agenda: 40th Tuberculosis and Leprosy Research Conference, US-Japan Cooperative Medical Science Program Aug. 6, 2007 Agenda: Medical Countermeasures against Combined Injury: Radiation with Burn, Blast, Trauma and/or Sepsis, March 26 - 27, 2007 Aug. 6, 2007 Agenda: Prevention of Group A Streptococcal Diseases and Their Sequelae Aug. 16, 2007 Agricultural Workers at Increased Risk for Infection with Animal Flu Viruses Nov. 25, 2005 AIDS Care in Africa Meeting, Kampala, Uganda, April 18-20, 2001, Slide 18, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001 AIDS Clinical Trials Group: Affiliated Clinical Trials Units and Clinical Research Sites July 24, 2007 AIDS Deaths in the United Stated: January 1985-June 1997, Slide 4, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999 AIDS Deaths in the United States, 1/86-9/98, Slide 4, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999 AIDS Deaths in the United States, 1985-2000, Slide 20, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001 AIDS Deaths in the United States, January 1986 - June 1998, Slide 2, Dr. Anthony S. Fauci, 1999 March 5, 1999 AIDS Deaths in the United States: January 1985-June 1997, Poster 2 Jan. 18, 2005 AIDS Deaths in the United States: January 1985-June 1997, Slide 1, Dr. Anthony S. Fauci, March 18, 1998 Jan. 15, 1999 AIDS Drugs Have Saved 3 Million Years of Life in the United States June 2, 2006 AIDS Research Advisory Committe, NIAID, NIH May 28, 2008 AIDS Research and Prevention, Slide 8, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999 AIDS Research, Slide 10, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999 AIDS Vaccine 2007 Report Jan. 8, 2008 AIDS Vaccine Research Highlights July 8, 1996 AIDS Vaccine Research Subcommittee (AVRS), Dec 2007, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH June 23, 2008 AIDS Vaccine Research Subcommittee (AVRS), May 2008, HIV/AIDS, Vaccines, DAIDS, NIAID, NIH July 17, 2008 AIDS Vaccine Research Working Group (AVRWG) Sept. 11, 2008 AIDS Vaccine Research Working Group (AVRWG) Committee Members, NIAID, NIH Dec. 14, 2007 AIDS Vaccine Research Working Group Archived Meeting Summaries, NIAID, NIH Oct. 18, 2007 AIDS Virus Reformatted to Shuttle Repair Genes to Diseased Brains April 11, 1996 Airborne Allergies: Something in the Air Feb. 12, 2008 Alan Sher, Immunobiology Section, Laboratory of Parasitic Diseases, NIAID, NIH Feb. 4, 2008 Alasdair M. Gilfillan, Ph.D., Mast Cell Biology Section, Laboratory of Allergic Diseases, NIAID, NIH July 8, 2008 Albert Z. Kapikian, M.D., Epidemiology Section, Laboratory of Infectious Diseases, NIAID, NIH May 22, 2006 Alfonso Gozalo, D.V.M., M.S., Veterinary Care, Comparative Medicine Branch, NIAID, NIH June 27, 2006 Alison McBride Ph.D., DNA Tumor Virus Section, Laboratory of Viral Diseases, NIAID, NIH Sept. 19, 2008 Allergic Diseases, NIAID, NIH April 24, 2008 Allergy / Immunology Fellowship Application Process, NIAID, NIH Dec. 26, 2007 Allergy and Immunology Training Program in the Division of Intramural Research (DIR), NIAID, NIH Nov. 13, 2006 Allergy News Releases, NIAID, NIH June 30, 2008 Allergy, Immunology, and Transplantation Research Committee, About NIAID, NIAID, NIH March 9, 2005 Alsner.pdf April 9, 2008 Alteration in Cell Death Pathway Sheds Light on Autoimmune Disease July 8, 1999 Amendment #1 (Questions and Answers) to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” Sept. 12, 2007 Amendment #1 (Questions and Answers) to RFP-NIH-NIAID-DMID-03-34, "Biodefense and Emerging Infections Research Resources Program" Sept. 12, 2007 Amendment #1 to RFP NIH-NIAID-DMID-03-54, “Construction Quality Management (CQM) Support Services” Sept. 12, 2007 Amendment #1 to RFP-NIH-NIAID-DAIT-04-38 Sept. 12, 2007 Amendment #1 to RFP-NIH-NIAID-DMID 04-34, "Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases" Sept. 12, 2007 Amendment #1 to RFP-NIH-NIAID-DMID-03-29, "Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine” Sept. 12, 2007 Amendment #1 to RFP-NIH-NIAID-DMID-03-45, "Administrative Resource for Biodefense Proteomic Centers" Sept. 12, 2007 Amendment #1, RFP NIH-NIAID-DMID-04-40, In Vitro and Animal Models for Emerging Diseases and BioDefense Sept. 12, 2007 Amendment #2 (Questions and Answers) to RFP-NIH-NIAID-DMID 04-34, "Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases" Sept. 12, 2007 Amendment #2 to RFP NIH-NIAID-DMID-03-45, “Administrative Resource for Biodenfense Proteomic Centers” Sept. 12, 2007 Amendment #2 to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” Sept. 12, 2007 Amendment #2 to RFP-NIH-NIAID-DMID-03-29, "Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine” Sept. 12, 2007 Amendment #2 to RFP-NIH-NIAID-DMID-03-34, "Biodefense and Emerging Infections Research Resources Program" Sept. 12, 2007 Amendment #3 to RFP NIH-NIAID-DMID-BAA-03-38, “Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology” Sept. 12, 2007 Amendment #3 to RFP-NIH-NIAID-DMID 04-34 Sept. 12, 2007 Amendment #3 to RFP-NIH-NIAID-DMID-03-29 Sept. 12, 2007 Amendment #4 to RFP NIH-NIAID-DMID-BAA-03-38 Sept. 12, 2007 Amendment #4, to RFP NIH-NIAID-DMID-03-45, “Administrative Resource for Biodenfense Proteomic Centers” Sept. 12, 2007 Amendment #5 to RFP NIH-NIAID-DMID-BAA-03-38 Sept. 12, 2007 Amendment of NIAID Solicitation RFP NIH-NIAID-DMID-03-39, "In vitro and Animal Models for Emerging Diseases and Biodefense" Sept. 12, 2007 Amino Acid Analysis and Conjugation Efficiency Assays, Technology, Peptide Synthesis, Research Technologies Branch, NIAID, NIH May 15, 2008 Amphipathic Oral Chelators and Radionuclide Contamination Dec. 26, 2007 An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United States July 20, 2007 An HIV Vaccine — Evolving Concepts, NEJM, May 16, 2007 Aug. 6, 2007 An HIV Vaccine — Evolving Concepts, NEJM, May 16, 2007 April 11, 2008 An HIV/AIDS Research Agenda in Developing Countries must be:, Slide 3, Dr. Esparza, July 7, 2001 July 6, 2001 An Ontological Representation of Complex Immunological Networks (Computing with Biological Knowledge) - Lindsay G. Cowell, Duke University Center for Computational Immunology July 24, 2007 An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-interferon Alfa 2b Every Two Weeks with Ribavirin Among HIV/HCV Coinfected Individuals May 15, 2008 Analyses, Technology, Mass Spectrometry, Research Technologies Branch, NIAID, NIH March 21, 2007 Andreassen.pdf April 9, 2008 Animal Models for Experimental Therapeutics and Vaccines Application Process, Services, DMID, NIAID, NIH July 7, 2008 Animal Models for Experimental Therapeutics and Vaccines Assurances, Services, DMID, NIAID, NIH July 7, 2008 Animal Models for Experimental Therapeutics and Vaccines Eligibility, Services, DMID, NIAID, NIH July 7, 2008 Animal Models for Hepatitis B and C Application, Services, DMID, NIAID July 3, 2008 Animal Models for Hepatitis B and C Assurances, Services, DMID, NIAID July 2, 2008 Animal Models for Hepatitis B and C Eligibility, Services, DMID, NIAID July 2, 2008 Animal Models for Hepatitis B and C Review, Services, DMID, NIAID July 3, 2008 Animal Models for Hepatitis B and C, Services, DMID, NIAID July 14, 2008 Animal Models for the Evaluation of Experimental Therapeutics and Vaccines Review Process, Services, DMID, NIAID, NIH July 7, 2008 Animal Models for the Evaluation of Experimental Therapeutics and Vaccines, Services, DMID, NIAID, NIH July 14, 2008 Animal Models, HIV/AIDS Vaccine Research, NIAID, NIH June 21, 2006 Animal Rule II: CDER Perspective/Case Studies, NIAID Workshop on Aerosolization Technolgies, December 4, 2003 Sept. 12, 2007 Animal Studies, Vaccines, NIAID, NIH July 17, 2008 Ankara Awards, Biodefense, NIAID, NIH Dec. 20, 2006 Ankara Awards, Biodefense, NIAID, NIH Dec. 20, 2006 Announcement of Availability of Overlapping Peptides for Influenza Proteome, January 27, 2006, Public Health Service, DHHS Aug. 6, 2007 Announcement of Funds Available for Pilot Grants from the Fred Hutchinson Cancer Research Center/ University of Washington Center for Medical Countermeasures Against Radiation (CMCR) Aug. 6, 2007 Announcement of Funds Available for Pilot Grants from the Fred Hutchinson Cancer Research Center/ University of Washington Center for Medical Countermeasures Against Radiation (CMCR), December 21, 2005 Aug. 6, 2007 Annual Commemerative Days, NIAID, NIH May 16, 2008 Anthony Fauci '58, Regis Alumni News Winter July 27, 2007 Anthony S. Fauci Awarded 2001 Frank Annunzio Award Oct. 4, 2001 Anthony S. Fauci Awarded Lasker Award for Public Service Sept. 14, 2007 Anthony S. Fauci Awarded the Highest Honor of the Association of American Physicians, NIAID, NIH April 13, 2007 Anthony S. Fauci to Present New Data on HIV Escape Mechanisms and HIV Suppressor Molecules Jan. 28, 1996 Anthony S. Fauci, M.D., Immunopathogenesis Section, Laboratory of Immunoregulation, NIAID, NIH May 12, 2008 Anthony S. Fauci, M.D., Lab Photo, 2007, NIAID, NIH April 13, 2007 Anthrax Awards, Biodefense, NIAID, NIH Dec. 20, 2006 Anthrax Genome Decoded April 30, 2003 Anthrax, NIAID, NIH Aug. 22, 2008 Antibiotic Therapy, Lyme Disease, NIAID, NIH Dec. 6, 2007 Antibodies Gone Awry, Multiple Sclerosis, NIAID, NIH Dec. 15, 2006 Antifungal Drug Helps Kids with Immune Disorder Avoid Hospitalization June 11, 2003 Antigen Research, Malaria Vaccine Development Branch, NIAID, NIH May 15, 2008 Antigenic Drift Illustration, How the Flu Virus Changes, Flu (Influenza), NIAID, NIH Dec. 4, 2006 Antigenic Drift vs. Antigenic Shift, How the Flu Virus Changes,Flu (Influenza), NIAID, NIH Dec. 4, 2006 Antigenic Shift Illustration, How the Flu Virus Changes,Flu (Influenza), NIAID, NIH Dec. 4, 2006 Anti-Herpes Drug Does Not Reduce Risk of HIV Infection in People with Genital Herpes Virus, Study Finds Feb. 6, 2008 Anti-HIV Treatment Improves Immune System and Fights Sight-Threatening Eye Infection Nov. 2, 1999 Antimicrobial (Drug) Resistance Research in NIAID Labs, NIH March 21, 2008 Antimicrobial (Drug) Resistance, NIAID, NIH June 16, 2008 Antimicrobial (Drug) Resistance: A Growing Health Issue, NIAID, NIH March 4, 2008 Antimicrobial Resistance - Selected Scientific Areas of Research Dec. 23, 2004 Antimicrobial Resistance News Releases, NIAID, NIH March 10, 2008 Antimicrobial Resistance: The NIH Response to a Growing Problem, Table of Contents, Dr. Anthony S. Fauci Feb. 23, 1999 Antimicrobial Resistance: The NIH Response to a Growing Problem. Statement of Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, February 25, 1999 Sept. 13, 1999 Antiretroviral Therapy (ART) to Reduce the Transmission of HIV, NIAID, NIH April 21, 2008 Antiviral Drug Development for Biothreat Agents - Tove Bolken, SIGA Technologies, Inc. Sept. 7, 2007 Appendices Aug. 6, 2007 Appendices July 26, 2007 Appendices - NIAID Profile FY 2003 Dec. 23, 2004 Appendix 1: DAIDS Guidance for Protocol Documents, NIAID, NIH Aug. 6, 2007 Appendix 1: Data Management Requirements for Data Collection Sites Aug. 6, 2007 Appendix 1: Essential Documents Recordkeeping Requirements Aug. 6, 2007 Appendix 1: Guidance on Study Monitoring Reports Aug. 6, 2007 Appendix 1: Required Site SOPS Aug. 6, 2007 Appendix 1: Source Documentation Requirements Aug. 6, 2007 Appendix 2: DAIDS Requirements for Non-U.S. Laboratories Guidance to Investigators Applying for Funding to Conduct HIV/AIDS Clinical Trials Aug. 6, 2007 Appendix 2: Data Management Requirements for Central Data Management Facilities Aug. 6, 2007 Appendix 2: Manual of Operations (MOP) Sample Table of Contents Aug. 6, 2007 Appendix 2: Study Progress and Safety Monitoring Plan Template Aug. 6, 2007 Appendix 3: Statistical Requirements Aug. 6, 2007 Appendix 6: DAIDS Independent Safetly Monitor (ISM) Guidelines Aug. 6, 2007 Appendix A 1 Oct. 9, 2007 Appendix A: Aerosol System Flow Oct. 9, 2007 Appendix A: Strategic Plan for Biodefense Research Sept. 7, 2007 Appendix B: Covered Sort Chamber Oct. 9, 2007 Appendix C: AeroTech Device Oct. 9, 2007 Appendix D: Position of the AeroTech Device Oct. 9, 2007 Appendix E: Glo-Germ Oct. 9, 2007 Appendix F: Collected Particles Oct. 9, 2007 Appendix G: Aerosol Cont. Report Oct. 9, 2007 Appendix H: Flow Lab Warning Oct. 9, 2007 Appendix I: Bio-Safety Suite Oct. 9, 2007 Appendix J: References Oct. 9, 2007 Application Information, Working at NIAID, NIH March 30, 2001 Application Process, Proteomics Research Centers, DMID, NIAID, NIH July 10, 2008 Application Process, Services for Preclinical Development of Therapeutic Agents, DMID, NIAID, NIH June 20, 2008 Application Process, Summer Internship Program in Biomedical Research, OTSEP, NIAID, NIH July 13, 2006 Approach to the Development of an HIV Vaccine, Poster 24 Jan. 18, 1999 Approaches to HIV Prevention, Poster 6 Jan. 18, 1999 Approaches to HIV Prevention, Slide 27, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001 Approaches to HIV Prevention, Slide 6, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999 Approaches to HIV Prevention, Slide 7, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999 Approaches to Potency Assays of Pre-and Prepro-Biologic Vaccines: The Role of RT-PCR and Genetic Stability in Characterizing Potency of Plasmnid DNA-based Vaccines April 11, 2008 Approval Process, Proteomics Research Centers, DMID, NIAID, NIH July 14, 2008 Approved Anit-HIV Drugs, Slide 5, Dr. Anthony S. Fauci, September 16, 1998 Jan. 14, 1999 Approved Anti-HIV Drugs, Slide 19, Dr. Anthony S. Fauci, July 7, 2001 July 7, 2001 Approved Anti-HIV Drugs, Slide 5, Dr. Anthony S. Fauci, July 9, 1999 July 16, 1999 Architectural Rendering, Building 33, NIAID, NIH May 1, 2006 Archive of Conferences and Meetings SummariesDivision of Allergy, Immunology, and Transplantation (DAIT), NIAID, NIH Aug. 9, 2005 Archive of NIAID in the News June 17, 2005 Arnold S. Kirshenbaum, M.D., Mast Cell Biology Section, Laboratory of Allergic Diseases, NIAID, NIH March 22, 2005 Article in Press, K.-L. Nguyen et al., Virology 2004 Aug. 1, 2007 Articles & Multimedia, Biodefense, NIAID, NIH Dec. 18, 2006 Ascariasis, NIAID, NIH Aug. 1, 2008 Asexual Blood-Stage Vaccines, Malaria Vaccine Development Branch, NIAID, NIH May 15, 2008 Ashish Jain, M.D., Clinical Immunology Unit, Laboratory of Host Defenses, NIAID, NIH March 12, 2008 Assay Requirements April 11, 2008 Assaying Potency of Novel Vaccines April 10, 2008 Assays For An AAV Vectored HIV Vaccine April 11, 2008 Assays for Bovine Viruses April 11, 2008 Association of American Physicians Presidential Address: The AIDS Model: Scientific and Policy Lessons for the 21st Century, Anthony S. Fauci July 19, 2007 Assurances, Preclinical Development of Therapeutic Agents, DMID, NIAID, NIH July 15, 2008 Asthma and Allergic Diseases, Selected Scientific Areas of Research Dec. 23, 2004 Asthma Facts, NIAID, NIH Sept. 3, 2008 Asthma News Releases Sept. 18, 2008 Asthma Research in NIAID Labs, NIAID, NIH April 29, 2008 Asthma Researchers Present New Results, New Perspectives on the Disease Feb. 25, 2002 Asthma, NIAID, NIH Sept. 19, 2008 Aton Pharma Dec. 26, 2007 Atopic Awards, Biodefense, NIAID, NIH Dec. 28, 2006 Attachment II: Safety Monitoring Committee (SMC) Guidelines, DMID, NIAID, NIH Aug. 6, 2007 Attachment III: Independent Safety Monitor (ISM) Guidelines, NIAID, NIH Aug. 6, 2007 Auchincloss Statement 10.4.07 May 12, 2008 Aug. 11, 2004 - Work on the Building Interior May 2, 2006 Augmented Designs to Assess Immune Response in Vaccine Trials Aug. 6, 2007 Australia, Western Pacific, Global Research, NIAID, NIH Nov. 9, 2007 Autoimmune Disease New Releases Aug. 13, 2008 Autoimmune Diseases - Selected Scientific Areas of Research Dec. 23, 2004 Autoimmune Diseases Research Plan, NIAID, NIH Sept. 14, 2007 Autoimmune Diseases, NIAID, NIH March 28, 2006 Autoimmune Lymphoproliferative Syndrome (ALPS), NIAID, NIH May 30, 2008 Autoimmune Reactivity, Lyme Disease, NIAID, NIH Dec. 6, 2007 Avian Influena - Pandemic Preparedness Dec. 26, 2007 AVRS May 2007 Summary Oct. 19, 2007 AVRSWorkshopAgendaSept2008.pdf Sept. 15, 2008 AVRWG Advice on Adenovirus Vectors, Jan 07, DAIDS, NIAID, NIH Aug. 6, 2007 AVRWG Workshop Summary, January 07, DAIDS, NIAID, NIH Aug. 6, 2007 Award Will Boost HIV/AIDS Research in China June 28, 2002 Awardees, Medical Countermeasures Against Radiological and Nuclear Threats, NIAID, NIH Oct. 5, 2007 Awards, Bioinformatics Resource Centers, NIAID, NIH Sept. 19, 2008 Awards, Centers of Excellence for Influenza Research and Surveillance, NIAID, NIH July 24, 2008 Awards, In Vitro and Animal Modules, Biodefense, NIAID, NIH March 10, 2008 Awards, Proteomics Research Centers, DMID, NIAID, NIH April 15, 2008

Home | Help | Site Index | Accessibility | Privacy Policy | Disclaimer | Links & Policies | FOIA | Contact Us National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH) Department of Health and Human Services (HHS)